CN103704701A - Angelica keiskei capsule and preparation method thereof - Google Patents
Angelica keiskei capsule and preparation method thereof Download PDFInfo
- Publication number
- CN103704701A CN103704701A CN201310742786.XA CN201310742786A CN103704701A CN 103704701 A CN103704701 A CN 103704701A CN 201310742786 A CN201310742786 A CN 201310742786A CN 103704701 A CN103704701 A CN 103704701A
- Authority
- CN
- China
- Prior art keywords
- angelica keiskei
- capsule
- powder
- arabinose
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001105098 Angelica keiskei Species 0.000 title claims abstract description 64
- 239000002775 capsule Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 23
- 235000016709 nutrition Nutrition 0.000 claims abstract description 8
- 239000000654 additive Substances 0.000 claims abstract description 7
- 230000000996 additive effect Effects 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 6
- 230000035764 nutrition Effects 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 22
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 235000020985 whole grains Nutrition 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 6
- 229960002079 calcium pantothenate Drugs 0.000 claims description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 102000008114 Selenoproteins Human genes 0.000 claims description 4
- 108010074686 Selenoproteins Proteins 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 4
- 239000011648 beta-carotene Substances 0.000 claims description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 4
- 229960002747 betacarotene Drugs 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 235000008160 pyridoxine Nutrition 0.000 claims description 4
- 239000011677 pyridoxine Substances 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019192 riboflavin Nutrition 0.000 claims description 4
- 239000002151 riboflavin Substances 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 4
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 4
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 4
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940068475 zinc citrate Drugs 0.000 claims description 4
- 235000006076 zinc citrate Nutrition 0.000 claims description 4
- 239000011746 zinc citrate Substances 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- 206010033546 Pallor Diseases 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000007605 air drying Methods 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- -1 through mixing Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000000227 grinding Methods 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000004806 packaging method and process Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000005453 pelletization Methods 0.000 abstract 1
- 238000009461 vacuum packaging Methods 0.000 description 11
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 241000125175 Angelica Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000106835 Bindesalat Species 0.000 description 1
- 235000000318 Bindesalat Nutrition 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 244000086443 Craterellus fallax Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 150000001480 arabinoses Chemical class 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 125000003051 glycosyloxy group Chemical group 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses an angelica keiskei capsule and a preparation method thereof. The angelica keiskei capsule is characterized by consisting of the following components in percentage by weight: 88-98 percent of angelica keiskei powder and 2-12 percent of L-arabinose. The angelica keiskei capsule is prepared through the steps of mixing, pelletizing, drying, granulating, uniform sub-packaging and packaging. The angelica keiskei capsule also comprises an additive which accounts for 0.5-5 percent of the total weight of the angelica keiskei powder and the L-arabinose, wherein the additive is a nutrition enhancer and an antioxidant. Angelica keiskei in the angelica keiskei capsule is fine powder which is prepared through green removing and drying according to an ultrafine grinding technology, wherein the grain size of the fine powder is 1,600-2,000 meshes, so that a product is large in distributivity, and facilitates metabolism and absorption; a finished product is accurate in dosage, easy to take, stable in quality, simple in production process and low in production cost, and can be popularized and applied; the nutritional ingredients and effects of the angelica keiskei can be kept.
Description
Technical field
The invention belongs to health food manufacture field, relate to the preparation method of a kind of Angelica Keiskei capsule and this capsule.
Background technology
Angelica Keiskei (Angelica keiskei koidz), has another name called tomorrow leaf, longevity grass, the grass of returning to life from the nether world, the grass of being bestowed by heaven, seapeak ginseng etc., is a kind of UmbrellaXing section (Umbelliferae), angelica (Angelica) herbaceos perennial.Be the rare species of food medicine dual-purpose, its tender leaf can be used as vegetables, and herb can hyoscine, and original producton location is Japanese Ba Zhang island, therefore have another name called eight zhang of grass.The areas such as existing Korea S, China Taiwan, Guizhou, Guangdong, Qingdao, Weihai have all formed scale plantation, are domestic emerging a kind of fashion healthy vegetable and the useful raw material of medical health care products.Recent domestic scientist is in the ascendant to the research of Angelica Keiskei, the analysis found that, Angelica Keiskei contains and maintains health, prevent aging necessary each seed amino acid, vitamin, mineral matter, the vegetal pole horn of plenties such as trace element, research also shows, in Angelica Keiskei rhizome, contain abundant natural flavone (flavonoid) and cumarin (coumarin), its stem, in leaf, contain multivitamin, carrotene, 16 seed amino acids, distinctive chalcone in protein and Angelica Keiskei, the compositions such as Coumarins, undoubtedly people by these precious natural green vegetables the laudatory title titled with " magical plant ".Tool research data shows, Angelica Keiskei is as healthy food use, and young stem and leaf can supply vegetables, generally stir-frying and eating, scald in river, cook, produce tea juice, make the methods such as tea bag and eat.Its whole plant for medical use, has heat-clearing, and diuresis is strong, the effect of lactagogue, and to hypertension, arteriosclerosis, diabetes, hepatopathy, flu, asthma, enterogastric diseases, rheumatism, insomnia, lung cancer, cancer of the stomach etc. all has effect.According to Osaka, Japan pharmaceutical university stud-farm Gui Mei river professor, wait research to find, that tomorrow leaf has is anti-ageing, antiulcer, antithrombotic, anticancer, hypotensive, regulate blood fat (reducing LDL-C, increasing high density lipoprotein cholesterol), hypoglycemic, improve the effects such as body immunity.Nowadays, on Japan, Korea S, Taiwan and other places, tomorrow leaf becomes the all-round food of " health, vigor, longevity ".The product that the Angelica Keiskei of take is made as primary raw material is domestic still few, as take Angelica Keiskei as primary raw material is prepared into capsule, also there is not yet at present reported in literature.
Summary of the invention
The object of this invention is to provide a kind of Angelica Keiskei capsule.Also be to provide a kind of preparation method of this capsule.
The present invention is achieved by the following scheme:
An Angelica Keiskei capsule, is characterized in that take that Angelica Keiskei powder, Arabinose are primary raw material, through mixing, granulates, dry, and whole grain, evenly packing, packing forms;
Described raw material carries out proportioning by following percentage by weight: Angelica Keiskei powder 88-98%, Arabinose 2-12%.
Wherein said Angelica Keiskei powder, can adopt Ultra-Micro Grinding Equipment to be ground into 1600-2000 object Ultramicro-powder.
In order to strengthen and improve the trophic function of Angelica Keiskei capsule, can also add the additive of Angelica Keiskei powder, Arabinose gross weight 0.5-5%.
Additive described above all can be buied the additive raw material that meets the relevant food sanitation standard of country by market.Mainly contain one or more the combination in nutrition fortifier (calcium activated, taurine, beta carotene, calcium pantothenate, folic acid, niacinamide, thiamine hydrochloride, riboflavin, pyridoxol, vitamin E, selenoprotein, zinc citrate etc.), antioxidant (as ascorbic acid, Tea Polyphenols etc.).
The combination of one or more of nutrition fortifier described above, antioxidant, all should pulverize the application of 500-800 mesh sieve.
The preparation method of Angelica Keiskei capsule of the present invention, is characterized in that Angelica Keiskei tender leaf through removal of impurities, cleans, completes, is dried, pulverizes, and then mixes with Arabinose, and granulation on granulator, dries, and through whole grain, evenly packing, makes capsule finished product.
The make a living face diameter that comes into leaves of Angelica Keiskei described above is no more than the tender leaf of 3cm;
Described completes, and is to adopt blanching 2-3min in 100 ℃ of boiling water that contain weight ratio 0.5% salt;
Described is dried as adopting air flow dryer, in 55-65 ℃ of low temperature heated-air drying to water content, is less than 2%.
Described pulverizing can adopt Ultra-Micro Grinding Equipment to be ground into 1600-2000 object Ultramicro-powder.
Described oven dry, be to adopt dryer, in 85-95 ℃, dries to particle water content and is less than 3%.
In order to make finished product be beneficial to storage, the packing of Angelica Keiskei capsule adopts vacuum packaging or nitrogen-filled packaging.
Arabinose
Arabinose is to obstruct from corncob, in pericarp hemicellulose, extract, the five carbon atom sugar that are isolated, arabinose is otherwise known as, its sugariness is half of sucrose, Arabinose itself is difficult to digested road and absorbs, even long-term, eat and also can not bring adverse effect to health, human body is not had to toxicity, the part being not used in vivo can be discharged metabolism and the absorption that suppresses sucrose from urine, therefore there is auxiliary blood sugar reducing function, Arabinose is as a kind of sugar low in calories, can suppress the blood sugar rising causing because taking in sucrose, prevention the treatment disease relevant to hyperglycaemia are played to the effect of assistant hypoglycemic, can reach the hypoglycemic effect of falling by the absorption of the sucrose in the high fat high-carbonhydrate diet of effective inhibition, can reduce and stabilizing blood sugar value, thereby play protection and repairing pancreas, the effect of prevention diabetes.The change effect of skeletal muscle fibre composition of Arabinose, affects the growth of stomach fat tissue by domination glycolysis to glycosyloxy, the change of this muscle fibre ratio is improved type II diabetes and fat effect.It is to suppress sucrase active in human small intestine that Arabinose acts on the most significantly, thereby regulate the excessive absorption of human body to sucrose, it can also activate in enteron aisle simultaneously, propagation beneficial bacterium, improve metabolic function, can regulate blood sugar, blood fat and minimizing fat accumulation, make it in fat-reducing, the application prospect of controlling the aspects such as diabetes is good, in addition also has combing skeletal muscle, the effects such as sterilizing oral, Arabinose has solved the healthy contradiction that not only keeps sweet taste but also green health, Arabinose, there is hypoglycemic and protect kidney, relax bowel, toxin-expelling and face nourishing, beauty and skin care, regulate blood sugar, the effects such as fat fat-reducing of dispelling, as raw material, be widely used in the specific crowd of " three high surpass " abroad.In May, 2008, Arabinose is approved as " new resource food " by health ministry.
Beneficial effect of the present invention
1, a kind of Angelica Keiskei capsule of the present invention, has kept the original nutritional labeling of Angelica Keiskei and beneficial functional to greatest extent, and product preparation process is simple, and production cost is low, is beneficial to suitability for industrialized production; Product dosage is accurate, is easy to swallow instant; In the present invention, Angelica Keiskei is processed and can be removed preferably the romaine lettuce taste of Angelica Keiskei through completing, and can effectively play the activity of eliminating enzyme, avoids finished product that oxidation deterioration occurs between the storage life, is conducive to the stability of product and ensures the quality of products.
2, the present invention also strengthened simultaneously product trophic function, make product have more trophism and strengthened health care.
3, the present invention adopts superfine grinding method to make Ultramicro-powder, can increase the surface tension of material composition, product is swallowed after distributivity increase, be beneficial to distribution, be of value to metabolism and the absorption of body, strengthen the effect of product.
The specific embodiment
Embodiment 1
Select new pluck fresh and the face diameter that comes into leaves of making a living is no more than the tender leaf of 3cm, reject the impurity such as rotten leaf, withered leaf and Lao Ye, water cleans up, be immersed in that to contain weight ratio be blanching 2-3min in 0.5% salt boiling water, and then drag in pure water rinsing 3 times, pull out, drain away the water, with air drier Low Temperature Thermal under the condition of 55-65 ℃ is air-dry, be dryly less than 2% to water content, with steam flow pulverizer, be ground into 1600-2000 object Ultramicro-powder, obtain Angelica Keiskei powder.
Embodiment 2
Getting 9.5 kilograms, Angelica Keiskei powder that embodiment 1 obtains fully mixes with 0.5 kilogram of Arabinose; also add Tea Polyphenols to mix (consumption of its Tea Polyphenols is by the conventional amount used of making food) simultaneously; granulation on granulator; then put in dryer, in 85-95 ℃, dry to particle water content and be less than 3%, then through whole grain; evenly packing; make every capsule that contains 1 gram, then adopt vacuum packing machine vacuum packaging, obtain Angelica Keiskei capsule finished product.
Embodiment 3
Getting 9.8 kilograms, Angelica Keiskei powder that embodiment 1 obtains fully mixes with 0.2 kilogram of Arabinose, also add thiamine hydrochloride simultaneously, riboflavin, pyridoxol, folic acid, calcium pantothenate, niacinamide, vitamin C mixes (thiamine hydrochloride wherein, riboflavin, pyridoxol, folic acid, calcium pantothenate, niacinamide, ascorbic consumption is by the conventional amount used of making food), granulation on granulator, then put in dryer, in 85-95 ℃, dry to particle water content and be less than 3%, again through whole grain, evenly packing, make every capsule that contains 1 gram, then adopt vacuum packing machine vacuum packaging, obtain Angelica Keiskei capsule finished product.
Embodiment 4
Getting 8.8 kilograms, Angelica Keiskei powder that embodiment 1 obtains fully mixes with 1.2 kilograms of Arabinoses; also add vitamin E, vitamin C, selenoprotein to mix (wherein the consumption of vitamin E, vitamin C, selenoprotein is by the conventional amount used of making food) simultaneously; granulation on granulator; then put in dryer; in 85-95 ℃, dry to particle water content and be less than 3%; again through whole grain; evenly packing; make every capsule that contains 1 gram; then adopt vacuum packing machine vacuum packaging, obtain Angelica Keiskei capsule finished product.
Embodiment 5
Getting 9 kilograms, Angelica Keiskei powder that embodiment 1 obtains fully mixes with 1 kilogram of Arabinose; also add calcium pantothenate, zinc citrate, Tea Polyphenols to mix (wherein the consumption of calcium pantothenate, zinc citrate, Tea Polyphenols is by the conventional amount used of making food) simultaneously; granulation on granulator; then put in dryer; in 85-95 ℃, dry to particle water content and be less than 3%; again through whole grain; evenly packing; make every capsule that contains 1 gram; then adopt vacuum packing machine vacuum packaging, obtain Angelica Keiskei capsule finished product.
Embodiment 6
Getting 9.2 kilograms, Angelica Keiskei powder that embodiment 1 obtains fully mixes with 0.8 kilogram of Arabinose, also add calcium activated simultaneously, taurine, beta carotene, vitamin C mixes (calcium activated wherein, taurine, beta carotene, ascorbic consumption is by the conventional amount used of making food), granulation on granulator, then put in dryer, in 85-95 ℃, dry to particle water content and be less than 3%, again through whole grain, evenly packing, make every capsule that contains 0.5 gram, then adopt vacuum packing machine vacuum packaging, obtain Angelica Keiskei capsule finished product.
Claims (11)
1. an Angelica Keiskei capsule, is characterized in that take that Angelica Keiskei powder, Arabinose are primary raw material, through mixing, granulates, dry, and whole grain, evenly packing, packing forms;
Described raw material carries out proportioning by following percentage by weight: Angelica Keiskei powder 88-98%, Arabinose 2-12%.
2. Angelica Keiskei capsule as claimed in claim 1, is characterized in that: described Angelica Keiskei powder is 1600-2000 object Ultramicro-powder.
3. Angelica Keiskei capsule as claimed in claim 1, is characterized in that: the additive that also comprises Angelica Keiskei powder, Arabinose gross weight 0.5-5% in raw material.
4. Angelica Keiskei capsule as claimed in claim 3, is characterized in that: described additive is nutrition fortifier, the antioxidant that meets the relevant food sanitation standard of country.
5. Angelica Keiskei capsule as claimed in claim 4; it is characterized in that: nutrition fortifier is calcium activated, taurine, beta carotene, calcium pantothenate, folic acid, niacinamide, thiamine hydrochloride, riboflavin, pyridoxol, vitamin E, selenoprotein, zinc citrate, antioxidant be in ascorbic acid, Tea Polyphenols one or both and above combination.
6. the Angelica Keiskei capsule as described in claim 4 or 5, is characterized in that: one or both of all nutrition fortifiers, antioxidant and above combination, all should pulverize the application of 500-800 mesh sieve.
7. a preparation method for Angelica Keiskei capsule as claimed in claim 1, is characterized in that Angelica Keiskei tender leaf through removal of impurities, cleans, completes, is dried, pulverizes, and then mixes with Arabinose; granulation on granulator, dries, through whole grain; evenly packing, makes capsule finished product.
8. the preparation method of Angelica Keiskei capsule according to claim 7, is characterized in that: the make a living face diameter that comes into leaves of described Angelica Keiskei tender leaf is no more than the tender leaf of 3cm.
9. the preparation method of Angelica Keiskei capsule according to claim 7, is characterized in that: described completes, and is to adopt blanching 2-3min in 100 ℃ of boiling water that contain weight ratio 0.5% salt.
10. the preparation method of Angelica Keiskei capsule according to claim 7, is characterized in that: described is dried as adopting air flow dryer to be less than 2% in 55-65 ℃ of low temperature heated-air drying to water content.
The preparation method of 11. Angelica Keiskei capsules according to claim 7, is characterized in that: described oven dry is for adopting dryer to dry to particle water content and be less than 3% in 85-95 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310742786.XA CN103704701B (en) | 2013-12-30 | 2013-12-30 | A kind of angelica keiskei capsule and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310742786.XA CN103704701B (en) | 2013-12-30 | 2013-12-30 | A kind of angelica keiskei capsule and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103704701A true CN103704701A (en) | 2014-04-09 |
| CN103704701B CN103704701B (en) | 2016-04-06 |
Family
ID=50398372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310742786.XA Active CN103704701B (en) | 2013-12-30 | 2013-12-30 | A kind of angelica keiskei capsule and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103704701B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732375A (en) * | 2010-01-11 | 2010-06-16 | 海南兰地高新科技有限公司 | Angelica keiskei mixed capsule and preparation method thereof |
| CN101810340A (en) * | 2010-04-23 | 2010-08-25 | 陈显刚 | Angelica keiskei soft capsule |
| CN101829160A (en) * | 2010-05-06 | 2010-09-15 | 广东省食品工业研究所 | Functional composition with functions of controlling blood sugar and enhancing nutrition |
| JP2013201968A (en) * | 2012-03-28 | 2013-10-07 | Calpis Co Ltd | Lactobacillus/acidophilus-containing food and beverage |
-
2013
- 2013-12-30 CN CN201310742786.XA patent/CN103704701B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732375A (en) * | 2010-01-11 | 2010-06-16 | 海南兰地高新科技有限公司 | Angelica keiskei mixed capsule and preparation method thereof |
| CN101810340A (en) * | 2010-04-23 | 2010-08-25 | 陈显刚 | Angelica keiskei soft capsule |
| CN101829160A (en) * | 2010-05-06 | 2010-09-15 | 广东省食品工业研究所 | Functional composition with functions of controlling blood sugar and enhancing nutrition |
| JP2013201968A (en) * | 2012-03-28 | 2013-10-07 | Calpis Co Ltd | Lactobacillus/acidophilus-containing food and beverage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103704701B (en) | 2016-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103005431B (en) | Seedless roxburgh rose-angelica keiskei composite chewable tablet and preparation method thereof | |
| CN111655048B (en) | Mat bamboo and preparation method and application thereof | |
| CN106616756A (en) | Preparation method of instant black sesame seed product | |
| CN103652692B (en) | Radish leaf nutritional chewable tablet and preparation method | |
| CN103919143A (en) | Roxburgh rose collagen tablet and preparing method thereof | |
| CN103461764A (en) | Flower crisp and preparation method thereof | |
| KR101046537B1 (en) | Noodles, tangerines, cheonggukjang flour, buckwheat containing noodles, kalguksu and cold noodles and noodles prepared by the above method | |
| CN103461844A (en) | Wild vegetable crisp chips and preparation method thereof | |
| CN107279403B (en) | Preparation method of health tea containing wisteria fruits and leaves | |
| KR20150077483A (en) | Sunshik Using Material of White and Black Food and Manufacturing Method Thereof | |
| CN103478529A (en) | Flower crisp chips and preparation method thereof | |
| CN102783621A (en) | Selenium-enriched purple sweet potato sheet jelly processing technology | |
| CN104138002A (en) | Health food with weight reducing function and preparing method of health food | |
| CN106962767A (en) | A kind of bletilla alimentary paste and preparation method thereof | |
| CN103109946A (en) | Beer belly tea bag and preparation method thereof | |
| CN105851139A (en) | Dendrobium officinale leaf cakes and production method thereof | |
| CN103750101A (en) | Angelica keiskei chewable tablet and preparation method thereof | |
| CN108740192A (en) | A kind of high dietary-fiber vine tea green juice powder and preparation method thereof | |
| CN103704701B (en) | A kind of angelica keiskei capsule and preparation method | |
| CN107279720A (en) | A kind of mulberry leaf manual factured hollow fine dried noodles and preparation method | |
| CN103444933B (en) | Tea bag for summer health-maintaining noon tea | |
| CN106490470A (en) | A kind of Radix Et Rhizoma Fagopyri Tatarici cocoa perfume noodles and preparation method thereof | |
| CN106261643A (en) | A kind of anti-ageing noodles of Rhizoma Dioscoreae and preparation method thereof | |
| CN102326736B (en) | Waxberry seed health noodle | |
| CN105876629A (en) | Dendrobium officinale leaf health-care noodles and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Yu Inventor after: Zhang Ruiqin Inventor before: Zhang Zhinian Inventor before: Request for anonymity |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160302 Address after: 221300, Xuzhou, Jiangsu province Pizhou City sheep Town sheep Village Applicant after: JIANGSU XINYUANRUI FOOD CO.,LTD. Address before: 221300, Jiangsu, Xuzhou province Pizhou City, sheep town, sun Lu Road on the east side Applicant before: XUZHOU GREEN FIELD BIOLOGY Co.,Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of Mingriye capsule and its preparation method Effective date of registration: 20221024 Granted publication date: 20160406 Pledgee: Jiangsu Zhangjiagang Rural Commercial Bank Co.,Ltd. Pizhou sub branch Pledgor: JIANGSU XINYUANRUI FOOD CO.,LTD. Registration number: Y2022320000600 |